Pre-Clinical Gap Analysis

Nucleus Network can assist Sponsors with gap analysis, regulatory strategy and due diligence for the intent of first-into-man studies.

We are able to conduct a review of pre-clinical and any clinical data that has been conducted to date that may affect the safety and tolerability of the Investigational Product in subjects for the proposed clinical development plan.